Source comparison
IGF-1 LR3 Results Timeline: Outcome Comparison by Research Endpoint
Different research applications measure different endpoints, and the IGF-1 LR3 results timeline varies accordingly. The table below summarizes expected timelines for the most common outcome measures in peptide research. Systemic IGF-1 Elevation 6–12 hours post
This comparison does not assign a generated winner or score.
- Different research applications measure different endpoints, and the IGF-1 LR3 results timeline varies accordingly. The table below summarizes expected timelines for the most common outcome measures in peptide research.
- Systemic IGF-1 Elevation
- 6–12 hours post-injection
- Plasma IGF-1 immunoassay
- Half-life 20–30 hrs; levels remain elevated 24–36 hrs per dose
- Receptor Binding & PI3K/Akt Activation
- 2–6 hours post-injection
- Western blot for phosphorylated Akt
- Receptor occupancy ≠ downstream effect; signaling detected before phenotype change
- Glycogen Supercompensation
- 24–48 hours
- Muscle biopsy glycogen assay
- Requires adequate carbohydrate intake; absent in ketogenic models
- Recovery Markers (DOMS, Force Production)
- 7–10 days
- Soreness scale, dynamometry
- Accelerated by twice-daily dosing; delayed if protein intake <1.6g/kg
- Nitrogen Retention & Protein Balance
- 10–14 days
- Nitrogen balance study, leucine oxidation test
- Requires leucine threshold (2.5–3g/meal); blunted in caloric deficit
- Lean Mass Accrual (Hypertrophy)
- 3–4 weeks
- DEXA, BIA, ultrasound cross-sectional area
- Requires resistance training stimulus; no change without mechanical tension
- Full Anabolic Plateau
- 6–8 weeks
- Weekly body composition tracking
- Plateau = adaptation, not failure; requires protocol adjustment to continue
- This comparison clarifies why some research models report 'immediate' IGF-1 LR3 results (receptor binding studies) while others report 'delayed' or 'null' results (hypertrophy studies terminating at 2 weeks). The endpoint determines the timeline. And the timeline determines when measurements should occur.